NCT02062658View on ClinicalTrials.gov

Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

Ketamine

0.5mg/kg IV

BEHAVIORAL

Exposure and Response Prevention

A type of Cognitive Behavioral Therapy called Exposure and Response Prevention.

Trial Locations (1)

10032

New York State Psychiatric Insitute, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT02062658 - Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP) | Biotech Hunter | Biotech Hunter